Showing results (111-120 of 192) with videos related to
Sort By:
Pageof 20
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.Acta Neuropathologica Communications|January 30, 2024
Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumorFrank M Mezzacappa, Frankie K Smith, Weiwei Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastomaChristopher E Pelloski, E Lin, Li Zhang, et al.Breast Cancer Research : BCR|March 15, 2014
A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivityRyan P McMullin, Ben S Wittner, Chuanwei Yang, et al.Oncotarget|April 18, 2018
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Lindsey D Goodman, Khalida M Wani, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2013
Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with cautionSandra H E Boots-Sprenger, Angelique Sijben, Jos Rijntjes, et al.Journal of Neurosurgery|August 10, 2010
Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical articleWael Hassaneen, Nicholas B Levine, Dima Suki, et al.Clinical Neuropathology|December 1, 2018
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic featuresAdriana Olar, Diep Tran, Vidya P Mehta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma CellsSameer Agnihotri, Sheila Mansouri, Kelly Burrell, et al.Pageof 20